Clinical Trial Update: Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 safety study examining autologous bone marrow-derived stem cells as a treatment for age-related macular degeneration, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Autologous bone marrow-derived stem cell therapy

Snippet

Sponsor: Al-Azhar University | Conditions: Age Related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN